首页 | 本学科首页   官方微博 | 高级检索  
     


Three-month Treatment Response and Exacerbation in Chronic Obstructive Pulmonary Disease
Authors:Jung Su Lee  Chin Kook Rhee  Kwang Ha Yoo  Ji-Hyun Lee  Ho Il Yoon  Tae-Hyung Kim  Woo Jin Kim  JinHwa Lee  Seong Yong Lim  Tai Sun Park  Jae Seung Lee  Sei Won Lee  Sang-Do Lee  Yeon-Mok Oh
Abstract:The aim of this study was to investigate relationships between acute exacerbation and Forced Expiratory Volume 1 second (FEV1) improvement after treatment with combined long-acting beta-agonist (LABA) and inhaled corticosteroid (ICS) in patients with chronic obstructive pulmonary disease (COPD). A total of 137 COPD patients were classified as responders or nonresponders according to FEV1 improvement after 3 months of LABA/ICS treatment in fourteen referral hospitals in Korea. Exacerbation occurrence in these two subgroups was compared over a period of 1 yr. Eighty of the 137 COPD patients (58.4%) were classified as responders and 57 (41.6%) as nonresponders. Acute exacerbations occurred in 25 patients (31.3%) in the responder group and in 26 patients (45.6%) in the nonresponder group (P=0.086). FEV1 improvement after LABA/ICS treatment was a significant prognostic factor for fewer acute exacerbations in a multivariate Cox proportional hazard model adjusted for age, sex, FEV1, smoking history, 6 min walk distance, body mass index, exacerbation history in the previous year, and dyspnea scale.Three-month treatment response to LABA/ICS might be a prognostic factor for the occurrence of acute exacerbation in COPD patients.

Graphical Abstract

Keywords:Pulmonary Disease, Chronic Obstructive   Forced Expiratory Volume   Disease Progression
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号